PROGNOSTIC VALUE OF BONE-MARROW PLASMA-CELL INFILTRATION IN STAGE-I MULTIPLE-MYELOMA

被引:27
作者
CAVO, M [1 ]
BACCARANI, M [1 ]
GOBBI, M [1 ]
LIPIZER, A [1 ]
TURA, S [1 ]
机构
[1] UNIV TRIESTE,CHAIR HAEMATOL,I-34127 TRIESTE,ITALY
关键词
D O I
10.1111/j.1365-2141.1983.tb02851.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:683 / 690
页数:8
相关论文
共 30 条
[1]  
ALEXANIAN R, 1980, BLOOD, V56, P521
[2]  
ALEXANIAN R, 1975, CANCER, V36, P1192, DOI 10.1002/1097-0142(197510)36:4<1192::AID-CNCR2820360403>3.0.CO
[3]  
2-I
[4]   TREATMENT FOR MULTIPLE MYELOMA - COMBINATION CHEMOTHERAPY WITH DIFFERENT MELPHALAN DOSE REGIMENS [J].
ALEXANIAN, R ;
HAUT, A ;
KHAN, AU ;
LANE, M ;
MCKELVEY, EM ;
MIGLIORE, PJ ;
STUCKEY, WJ ;
WILSON, HE .
JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1969, 208 (09) :1680-+
[5]   BONE-MARROW HISTOLOGY IN MYELOMA - ITS IMPORTANCE IN DIAGNOSIS, PROGNOSIS, CLASSIFICATION AND STAGING [J].
BARTL, R ;
FRISCH, B ;
BURKHARDT, R ;
FATEHMOGHADAM, A ;
MAHL, G ;
GIERSTER, P ;
SUND, M ;
KETTNER, G .
BRITISH JOURNAL OF HAEMATOLOGY, 1982, 51 (03) :361-375
[6]   TREATMENT OF PLASMA-CELL MYELOMA [J].
BERGSAGEL, DE .
ANNUAL REVIEW OF MEDICINE, 1979, 30 :431-443
[7]  
CASSUTO JP, 1977, BIOMED EXPRESS, V27, P197
[8]  
CAVO M, 1982, HAEMATOLOGICA, V67, P760
[9]  
COSTA G, 1969, P AM ASSOC CANC RES, V10, P15
[10]   RELATION OF OSTEOCLAST ACTIVATING FACTOR PRODUCTION TO EXTENT OF BONE-DISEASE IN MULTIPLE-MYELOMA [J].
DURIE, BGM ;
SALMON, SE ;
MUNDY, GR .
BRITISH JOURNAL OF HAEMATOLOGY, 1981, 47 (01) :21-30